West is collaborating with Noble to provide multisensory-based educational and training programs for wearable self-injection systems. The SmartDose injector

West and Noble inject multisensory aspect into digital training

West Pharmaceutical Services is collaborating with Noble, a patient-centric training company, to provide multisensory-based educational and training programmes for wearable self-injection systems

West said that the collaboration will enable it to offer training solutions for its SmartDose electronic wearable injector and other self-administration systems.

Chris Evans, vice president of research and innovation at West, said: “Advancements in biologic products coupled with the shift to patient self-care in the home setting have driven the need for enhanced self-injection systems.

“We work by the side of our customers and partners to optimise the experience of patients who self-inject in a way that increases affinity, overcomes initial training and onboarding challenges as well as fostering adherence to a treatment regimen.”

According to a study by Noble and analysed by Auburn University, more than 60% of patients reported that they did not thoroughly read the required steps outlined in a self-injection system’s instructions for use document prior to beginning drug treatment.

Noble said it incorperates this fact into the development of its patient training technologies and education materials, including instructions for use, onboarding, smart training devices and packaging.

Craig Baker, executive vice resident at Noble, said: “New patients with self-injectors often make errors in administration.

“Research from both West and Noble revealed that patient-friendly delivery systems and comprehensive education around self-injection are needed to improve the patient experience.”


'West and Noble inject multisensory aspect into digital training' has no comments

Be the first to comment this post!

Would you like to share your thoughts?

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

© 2018 Rapid Life Sciences Ltd, a Rapid News Communications Group Company. All Rights Reserved.

Privacy policy

Terms and conditions